z-logo
open-access-imgOpen Access
Change in the value of the QT interval at various stages of the perioperative period in patients with coronary ischemic heart disease under general anesthesia
Author(s) -
В. П. Михин,
С. А. Сумин,
Н. А. Волкова,
E. N. Bogoslovskaya,
П. А. Еремин,
Н. Н. Авдеева,
N. I. Gromnatsky,
Viktor V. Anikin
Publication year - 2021
Publication title -
čelovek i ego zdorovʹe
Language(s) - English
Resource type - Journals
eISSN - 1998-5754
pISSN - 1998-5746
DOI - 10.21626/vestnik/2021-3/03
Subject(s) - qt interval , perioperative , medicine , anesthesia , cardiology
Objective. To evaluate the status of QT interval derivatives in patients with chronic IHD during different perioperative periods of planned open cholecystectomy under general anaesthesia and to determine the possibility of using meldonium for prevention of QT interval dysfunction. Materials and methods. Patients with the diagnosis of cholelithiasis with verified forms of chronic CHD (angina I and II AC) were divided into 2 groups: Group 1 was the control group with conventional perioperative therapy, and Group 2 was the main group with additional meldonium. The dynamics of the corrected QT interval (QTc) and the variance of the QT interval (DQT) were assessed. Analysis was performed by means of daily Holter ECG monitoring, in which 6 time periods were singled out: 1 - the day before the operation (18 hours); 2 - hours before the operation; 3 - induction into anesthesia; 4 - maintenance of anesthesia; 5 - withdrawal from anesthesia; 6 - the day 2 after the operation (18 hours). Results. The increase in QTc and DQT values during induction, maintenance and withdrawal from anesthesia was detected only in the control group. The inclusion of meldonium in perioperative therapy in patients with CHD was accompanied by the absence of QTc interval prolongation and an increase in DQT values in the periods of induction, exit and maintenance of anaesthesia. Conclusion. The perioperative period was accompanied by a prolongation of the QTc interval and an increase in DQT values in the group receiving conventional therapy. The inclusion of meldonium was accompanied by no increase in QTc and DQT during most follow-up periods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here